Forward Science Technologies , the developer of the OralID cancer screening device, has added to its line of oral healthcare products with its new chairside oral pH test, called phID.
The test allows practitioners to quantify the oral pH of their patients and quantify the risks associated with each patient, according to the company.
"By knowing the pH of our patients saliva, we can determine their buffering capacity as it relates to remineralization, increased risk for caries infections, and optimize treatment recommendations," stated Debbie Sabatini, RDH, OralID representative and oral health advocate, in a press release.
